Olaparib – November 2022

• Brand names:
  • Lynparza®
• Pharmaceutical Company:
  • AstraZeneca Pty Ltd
• Condition/Indication: Ovarian cancer
• Meeting Date: November 2022
• Public Summary Document (PSD) November 2022 July 2023 PBAC Meetings - (PDF 729KB)
• Public Summary Document (PSD) November 2022 July 2023 PBAC Meetings - (Word 322KB)

Related Public Summary Documents

Olaparib – July 2023